| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/02/2010 | US7655238 Fusing to the antigen a Listerial truncated ActA protein; Listeria vaccine strains |
| 02/02/2010 | US7655236 Lanthionine antibiotic compositions and methods |
| 02/02/2010 | US7655235 DNA vaccination which polynucleotides encode an HIV envelope protein; acquired immune deficiency syndrome (AIDS) |
| 02/02/2010 | US7655234 Inhibiting growth of a solid tumor cell that expresses the protein; cancer diagnosis |
| 02/02/2010 | US7655223 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 02/02/2010 | US7655222 increase the production of monocytic cells or moncyte cell progenitors by culturing bone marrow or blood cells with a polypeptide for use in treatment and prevention of viral hepatitis diseases; N-terminal methionine; rheumatoid arthritis, multiple sclerosis, myasthenia gravis, systemic lupus, leukemia |
| 02/02/2010 | US7655216 nontarget antigen to sensitize a patient's CD8+ T cells followed with administration of a vaccine comprising a target antigen (such as a tumor-associated antigen or a pathogen-associated antigen); cancer and autoimmune diseases |
| 02/02/2010 | CA2585164C Nucleotides sequences derived from the genome of type hiv-1, hiv-2 and siv retroviruses, and their applications especially for the amplification the genomes of these retroviruses and for in vitro diagnosis of infections due to these viruses |
| 02/02/2010 | CA2479494C Compositions and methods associated with pro5725 and its use for the diagnosis of lung and colon tumor |
| 02/02/2010 | CA2456042C Method for the preparation of gliadin-and glutenin-rich fractions out of gluten in an aqueous medium and in the presence of an acid |
| 02/02/2010 | CA2453518C Nucleic acid-free bacterial ghost preparation formed by co-expression of lytic and nuclease genes |
| 02/02/2010 | CA2451394C Il-4 receptor sequence variation associated with type 1 diabetes |
| 02/02/2010 | CA2439051C Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 02/02/2010 | CA2387473C Improved method for the detection of acid resistant microorganisms in a stool |
| 02/02/2010 | CA2373519C Corn oil and protein extraction method |
| 02/02/2010 | CA2332561C Compound capable of inhibiting the binding of a protein to mast cells, use of the compound for the preparation of a drug, a pharmaceutical composition, a method of diagnosing a disease, and a method of selection |
| 02/02/2010 | CA2327524C Method of controlling cleavage by ompt protease |
| 02/02/2010 | CA2302779C Recombinant mhc molecules useful for manipulation of antigen-specific t-cells |
| 02/02/2010 | CA2293724C Apaf-1, the ced-4 human homolog, an activator of caspase-3 |
| 02/02/2010 | CA2282842C A method of recovering highly purified vwf or factor viii/vwf-complex |
| 02/02/2010 | CA2272573C Peptide derived from an antigen recognized by autoantibodies from patients with rheumatoid arthritis, antibody directed against said peptide, a combinatorial antigen, and a methodof detecting auto-immune antibodies |
| 02/02/2010 | CA2257973C T cell antigen receptor peptides |
| 02/02/2010 | CA2230885C Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 02/02/2010 | CA2204277C Combined meningitis vaccine |
| 02/02/2010 | CA2196286C Parallel selex |
| 02/02/2010 | CA2180425C Purified primate ctla-8 antigens and related reagents |
| 02/02/2010 | CA2160937C Survival motor neuron (smn) gene: a gene for spinal muscular atrophy |
| 02/02/2010 | CA2146974C Direct selection of cells by secretion product |
| 02/02/2010 | CA2142331C Immunoglobulins devoid of light chains |
| 02/02/2010 | CA2080684C Bacillus thuringiensis cryif and cryix genes and proteins toxic to lepidopteran insects |
| 02/01/2010 | CA2638176A1 Oligonucleotide and use thereof |
| 01/28/2010 | WO2010011994A2 Polypeptides and uses thereof |
| 01/28/2010 | WO2010011960A2 Triple acting antimicrobials that are refractory to resistance development |
| 01/28/2010 | WO2010011947A2 AMYLOID ß PEPTIDE ANALOGUES, OLIGOMERS THEREOF, PROCESSES FOR PREPARING AND COMPOSITIONS COMPRISING SAID ANALOGUES OR OLIGOMERS, AND THEIR USES |
| 01/28/2010 | WO2010011907A2 Plants with altered root architecture, related constructs and methods involving genes encoding rep2 polypeptides and homologs thereof |
| 01/28/2010 | WO2010011735A2 Modified bovine g-csf polypeptides and their uses |
| 01/28/2010 | WO2010011693A2 Proteins containing expanded polyglutamine tracts induce mitochondrial fragmentation by disrupting mitochondrial fusion |
| 01/28/2010 | WO2010011439A2 Gip-based mixed agonists for treatment of metabolic disorders and obesity |
| 01/28/2010 | WO2010011313A2 Ligation of stapled polypeptides |
| 01/28/2010 | WO2010011284A2 Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides |
| 01/28/2010 | WO2010010862A1 Method for construction of artificial rnp nano-structure by utilizing rna-protein complex interaction motif |
| 01/28/2010 | WO2010010848A1 Method for production of antibody in cultured mammalian cell by using molecular chaperone |
| 01/28/2010 | WO2010010674A1 FUCOSE α1→6-SPECIFIC LECTIN |
| 01/28/2010 | WO2010010551A2 Novel angiopoietin derived peptides |
| 01/28/2010 | WO2010010532A1 Syndecan-4 is a regulator of rac1-gtp |
| 01/28/2010 | WO2010010469A2 Abeta (x-38..43) oligomers, and processes, compositions, and uses thereof |
| 01/28/2010 | WO2010010223A1 Use of microparticles containing genetically modified cells in the treatment of neurodegenerative diseases |
| 01/28/2010 | WO2010010180A1 Novel compositions and methods |
| 01/28/2010 | WO2010010179A1 The tuberculosis rv2386c protein, compositions and uses thereof |
| 01/28/2010 | WO2010010178A1 The tuberculosis rv2707c protein, compositions and uses thereof |
| 01/28/2010 | WO2010010177A1 Novel compositions and methods |
| 01/28/2010 | WO2010010145A1 Keratin-binding polypeptides and method for their identification |
| 01/28/2010 | WO2010010051A1 Tnfsf single chain molecules |
| 01/28/2010 | WO2010009732A1 Therapeutic use of a growth factor, metrnl |
| 01/28/2010 | WO2010009614A1 Secretion expression of antibiotic peptide cad in bacillus subtilis and expression system of recombination bacillus subtilis |
| 01/28/2010 | WO2010009534A1 Methods for the treatment, prevention and diagnosis of lipid metabolism associated diseases |
| 01/28/2010 | WO2009151491A9 In vivo incorporation of an unnatural amino acid comprising a 1,2-aminothiol group |
| 01/28/2010 | WO2009148549A3 Novel biosensors for live cell imaging of intracellular proteins |
| 01/28/2010 | WO2009147384A3 Peptides derived from the neural-restrictive silencer factor rest and use thereof |
| 01/28/2010 | WO2009147201A3 Anti-inflammatory agents |
| 01/28/2010 | WO2009137837A3 Neuregulin/erbb signaling and integrin |
| 01/28/2010 | WO2009108261A3 Compositions and methods for the treatment of viral infections |
| 01/28/2010 | WO2009024631A3 A combination of inhibitors of tgfbeta-1 and matrix metalloproteins for use in the treatment of bone metastases, bone resorption and hypercalcaemia |
| 01/28/2010 | WO2009009767A3 New bacillus thuringiensis toxin |
| 01/28/2010 | WO2007112122A8 Methods of producing and using cold temperature tolerant plants, seeds, and crops |
| 01/28/2010 | WO2007000768A9 Gliomedin, fragments thereof and methods of using same |
| 01/28/2010 | WO2006020326A9 Methods of identifying compounds that modulate protein activity |
| 01/28/2010 | WO2004094604A9 Splice variants of human voltage-gated calcium channel alpha2delta-2 subunit designated-alpha2delta2-a and alpha2delta2-b |
| 01/28/2010 | WO2004005463A9 Tumor antigens bfa4 and bcy1 for prevention and/or treatment of cancer |
| 01/28/2010 | WO2004001003A9 Plastid division and related genes and proteins, and methods of use |
| 01/28/2010 | WO2003076644A9 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/28/2010 | WO2003061603A9 Global suppressors of p53 mutations |
| 01/28/2010 | WO2003016502A9 Tramdorins and methods of using tramdorins |
| 01/28/2010 | US20100024079 Nucleic Acid Molecules and Other Molecules Associated with Plants |
| 01/28/2010 | US20100024069 Expression and use of novel pesticidal toxins |
| 01/28/2010 | US20100024068 Antimicrobial Peptides and Uses Thereof |
| 01/28/2010 | US20100024067 Plants having enhanced seed yield-related traits and a method for making the same |
| 01/28/2010 | US20100024050 Pufa polyketide synthase systems and uses thereof |
| 01/28/2010 | US20100024047 Prion-free transgenic ungulates |
| 01/28/2010 | US20100022760 Mutant protein |
| 01/28/2010 | US20100022758 Pyroglue |
| 01/28/2010 | US20100022756 Trimerising Module |
| 01/28/2010 | US20100022755 Platelet aggregation inducing substance |
| 01/28/2010 | US20100022752 Identifying components of a network having high importance for network integrity |
| 01/28/2010 | US20100022751 Recombinant toxin fragments |
| 01/28/2010 | US20100022456 Dimeric Prolactin Receptor Ligands |
| 01/28/2010 | US20100022454 Peptides with High Affinity for the Prolactin Receptor |
| 01/28/2010 | US20100022453 NoGo Receptor 1 and Fibroblast Growth Factor Interactions |
| 01/28/2010 | US20100022452 Nanobodies for the treatment of aggregation-mediated disorders |
| 01/28/2010 | US20100022438 Method of separating carbon nanotubes |
| 01/28/2010 | US20100022404 Gene/protein marker for prediction or diagnosis of pharmacological efficacy of aurora a inhibitor |
| 01/28/2010 | US20100022401 Avidin-like proteins from symbiotic bacteria |
| 01/28/2010 | US20100022028 Human ox2 receptors |
| 01/28/2010 | US20100022027 Gene 763 of phytopathogenic fungus magnaporthe grisea and use thereof for identifying fungicidal compounds |
| 01/28/2010 | US20100022017 Inorganic phosphate assays |
| 01/28/2010 | US20100022016 Polyamide nucleic acid derivatives and agents, and processes for preparing them |
| 01/28/2010 | US20100021997 Biologically active recombinant human saposin C and PSAP |
| 01/28/2010 | US20100021966 Method for the Preparation of Growth Hormone and Antagonist Thereof Having Lower Levels of Isoform Impurities Thereof |
| 01/28/2010 | US20100021957 Functionalized quantum dots and methods for preparing them |
| 01/28/2010 | US20100021951 Human Brain Carboxypeptidase B |